Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$280,727
-$21,566 QoQ
Shares Held
2,222
+2.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,695
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $9,117,824 across 12 Drug Manufacturers - General names. GILD ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,426 | $2,909,817 | |
| 2 | JNJ |
Johnson & Johnson
|
9,783 | $2,484,588 | |
| 3 | ABBV |
AbbVie Inc.
|
8,090 | $2,035,767 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,717 | $863,134 | |
| 5 | AMGN |
Amgen Inc
|
1,126 | $407,747 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
2,222 | $280,727 | |
| 7 | PFE |
Pfizer Inc
|
2,704 | $65,112 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
648 | $37,337 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $280,727 | 2,222 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $302,293 | 2,169 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $266,223 | 2,169 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $223,887 | 2,017 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $223,624 | 2,017 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $251,776 | 2,247 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $207,555 | 2,247 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $188,388 | 2,247 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $154,166 | 2,247 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $164,592 | 2,247 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $183,244 | 2,262 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $168,390 | 2,247 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $173,176 | 2,247 | Shares | Sole | 2023-12-18 | |
| 2023-03-31 | $186,433 | 2,247 | Shares | Sole | 2023-12-18 | |
| 2022-12-31 | $189,900 | 2,212 | Shares | Sole | 2023-12-18 | |
| 2022-09-30 | $136,458 | 2,212 | Shares | Sole | 2023-12-19 | |
| 2022-06-30 | $136,723 | 2,212 | Shares | Sole | 2023-12-19 | |
| 2022-03-31 | $131,503 | 2,212 | Shares | Sole | 2023-12-19 | |
| 2021-12-31 | $160,613 | 2,212 | Shares | Sole | 2023-12-20 | |
| 2021-09-30 | $74,041 | 1,060 | Shares | Sole | 2023-12-20 | |
| 2021-06-30 | $72,991 | 1,060 | Shares | Sole | 2023-12-20 | |
| 2021-03-31 | $68,507 | 1,060 | Shares | Sole | 2023-12-20 | |
| 2020-12-31 | $61,755 | 1,060 | Shares | Sole | 2023-12-20 | |
| 2020-09-30 | $66,981 | 1,060 | Shares | Sole | 2023-12-20 | |
| 2020-06-30 | $81,556 | 1,060 | Shares | Sole | 2023-12-20 | |
| 2020-03-31 | $79,245 | 1,060 | Shares | Sole | 2023-12-21 | |
| No filing history on record for this holder in this stock. | ||||||